Omeros Q4 Adj. EPS $3.14 Beats $(0.57) Estimate
3/31/2026
Impact: 100
Healthcare
Omeros (NASDAQ: OMER) reported a Q4 adjusted EPS of $3.14, significantly surpassing the analyst consensus estimate of $(0.57) by 650.88%. This marks a substantial increase of 598.41% compared to losses of $(0.63) per share in the same quarter last year.
AI summary, not financial advice
Share: